Xenetic Biosciences Reports 2017 Second Quarter Financial Results and Provides Business Update

Go back to Xenetic Biosciences Reports 2017 Second Quarter Financial Results and Provides Business Update

Xenetic Biosciences (XBIO) Reports Q2 Loss of $0.34/Share

August 15, 2017 8:12 AM EDT

Xenetic Biosciences (NASDAQ: XBIO) reported Q2 EPS of ($0.34), versus ($6.12) reported last year.

For earnings history and earnings-related data on Xenetic Biosciences (XBIO) click here.

... More